The production line independently developed by CATL features a high degree of complexity and intelligence, combined with advanced materials science. This should continue to set high entry barriers, ...

Radio-DARPin MP0712 against DLL3, in co-development with Orano Med, to enter first-in-human study in 2025 Mesothelin named as second target in Radio-DARPin pipeline, program to be co-developed with ...

To this session of the Morgan Stanley Global Healthcare Conference. I'm excited to welcome the team from 4D Molecular Therapeutics. Let me just get through a quick disclosure before we get started.

Detailed price information for Molecular Partners Ag ADR (MOLN-Q) from The Globe and Mail including charting and trades.

If you have been weighing what to do with Bristol-Myers Squibb (BMY), recent company updates might make you pause and ...

Terns Pharmaceuticals, Inc. ( NASDAQ: TERN) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 10:00 AM EDT ...